日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

The interaction of tPA with NMDAR1 drives neuroinflammation and neurodegeneration in α-synuclein-mediated neurotoxicity

tPA与NMDAR1的相互作用驱动α-突触核蛋白介导的神经毒性中的神经炎症和神经退行性变。

Daniel Torrente ,Enming J Su ,Alí Francisco Citalán-Madrid ,Gerald P Schielke ,Daniel Magaoay ,Mark Warnock ,Tamara Stevenson ,Kris Mann ,Flavie Lesept ,Nathalie Delétage ,Manuel Blanc ,Erin H Norris ,Denis Vivien ,Daniel A Lawrence

RECITAL: a non-inferiority randomised control trial evaluating a virtual fracture clinic compared with in-person care for people with simple fractures (study protocol)

RECITAL:一项非劣效性随机对照试验,评估虚拟骨折诊所与面对面治疗对简单骨折患者的疗效(研究方案)

Teng, Min Jiat; Zadro, Joshua R; Pickles, Kristen; Copp, Tessa; Shaw, Miranda J; Khoudair, Isabella; Horsley, Mark; Warnock, Benjamin; Hutchings, Owen R; Petchell, Jeffrey F; Ackerman, Ilana N; Drayton, Alison; Liu, Rong; Maher, Christopher G; Traeger, Adrian C

Magnetically powered microwheel thrombolysis of occlusive thrombi in zebrafish

磁力驱动微轮溶解斑马鱼闭塞性血栓

M Hao Hao Pontius, Chia-Jui Ku, Matthew J Osmond, Dante Disharoon, Yang Liu, Mark Warnock, Daniel A Lawrence, David W M Marr, Keith B Neeves, Jordan A Shavit

Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicity

β-2 和 β-1 肾上腺素能受体信号传导对 α-突触核蛋白介导的神经毒性中的神经炎症和多巴胺能神经元存活的相反作用

Daniel Torrente ,Enming J Su ,Gerald P Schielke ,Mark Warnock ,Kris Mann ,Daniel A Lawrence

Compartmentalized Actions of the Plasminogen Activator Inhibitors, PAI-1 and Nsp, in Ischemic Stroke

纤溶酶原激活剂抑制剂 PAI-1 和 Nsp 在缺血性中风中的区域化作用

Daniel Torrente #, Enming Joseph Su #, Linda Fredriksson, Mark Warnock, David Bushart, Kris M Mann, Cory D Emal, Daniel A Lawrence

Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients

住院 COVID-19 患者血浆组织型纤溶酶原激活剂和纤溶酶原激活剂抑制剂-1

Yu Zuo, Mark Warnock, Alyssa Harbaugh, Srilakshmi Yalavarthi, Kelsey Gockman, Melanie Zuo, Jacqueline A Madison, Jason S Knight, Yogendra Kanthi, Daniel A Lawrence

Dual-reporter high-throughput screen for small-molecule in vivo inhibitors of plasminogen activator inhibitor type-1 yields a clinical lead candidate

双报告基因高通量筛选纤溶酶原激活剂抑制剂 1 型的小分子体内抑制剂,产生临床先导候选药物

Ashley A Reinke, Shih-Hon Li, Mark Warnock, Maxim E Shaydakov, Naga Sandhya Guntaka, Enming J Su, Jose A Diaz, Cory D Emal, Daniel A Lawrence

CpaA Is a Glycan-Specific Adamalysin-like Protease Secreted by Acinetobacter baumannii That Inactivates Coagulation Factor XII

CpaA 是一种由鲍曼不动杆菌分泌的聚糖特异性 Adamalysin 样蛋白酶,可灭活凝血因子 XII

Ursula Waack, Mark Warnock, Andrew Yee, Zachary Huttinger, Sara Smith, Ayush Kumar, Alban Deroux, David Ginsburg, Harry L T Mobley, Daniel A Lawrence, Maria Sandkvist0

Angiotensin 1-7 and Mas decrease thrombosis in Bdkrb2-/- mice by increasing NO and prostacyclin to reduce platelet spreading and glycoprotein VI activation

血管紧张素 1-7 和 Mas 通过增加 NO 和前列环素来减少血小板扩散和糖蛋白 VI 活化,从而减少 Bdkrb2-/- 小鼠的血栓形成

Chao Fang, Evi Stavrou, Alec A Schmaier, Nadja Grobe, Mariana Morris, Andrew Chen, Marvin T Nieman, Gregory N Adams, Gretchen LaRusch, Yihua Zhou, Matthew L Bilodeau, Fakhri Mahdi, Mark Warnock, Alvin H Schmaier

The vitronectin-binding function of PAI-1 exacerbates lung fibrosis in mice

PAI-1 的玻璃粘连蛋白结合功能加剧小鼠肺纤维化

Anthony J Courey, Jeffrey C Horowitz, Kevin K Kim, Timothy J Koh, Margaret L Novak, Natalya Subbotina, Mark Warnock, Bing Xue, Andrew K Cunningham, Yujing Lin, Monica P Goldklang, Richard H Simon, Daniel A Lawrence, Thomas H Sisson